Correlation Between Spero Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Spero Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Revelation Biosciences.
Diversification Opportunities for Spero Therapeutics and Revelation Biosciences
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spero and Revelation is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Spero Therapeutics is expected to generate 0.33 times more return on investment than Revelation Biosciences. However, Spero Therapeutics is 3.04 times less risky than Revelation Biosciences. It trades about -0.03 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.06 per unit of risk. If you would invest 180.00 in Spero Therapeutics on August 31, 2024 and sell it today you would lose (66.00) from holding Spero Therapeutics or give up 36.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.73% |
| Values | Daily Returns |
Spero Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| Spero Therapeutics |
| Revelation Biosciences |
Spero Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Spero Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| Revelation Biosciences vs. Cue Biopharma | Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. Inhibrx | Revelation Biosciences vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |